MetaCap

ICU Medical (ICUI) vs iRhythm (IRTC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

ICU Medical (ICUI) has outperformed iRhythm (IRTC) over the past year, gaining 32.1% versus a loss of 40.9%. Over five years, IRTC leads with a +45.2% price change compared with -32.4% for ICUI. ICU Medical is the larger company by market cap ($3.93 billion vs $3.36 billion), about 1.2 times the size, while iRhythm is growing revenue faster (+26.2% vs -6.3%).

On valuation, ICU Medical trades at a lower forward P/E (16.3x vs 79.6x for iRhythm). ICU Medical converts more of its revenue into profit, with a net margin of 0.0% versus -6.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ICUI+32.12%IRTC-40.89%
+64%+8%-48%
Oct 7, 20251 yearOct 7, 2026
ICUI-31.60%IRTC+66.12%
+211%+67%-77%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ICUI versus IRTC key metrics
MetricICUIIRTC
Share price$156.96$102.05
Market cap$3.93B$3.36B
1-day change+0.60%-2.81%
YTD return+9.36%-40.83%
1-year return+32.12%-40.89%
5-year return-32.41%+45.23%
P/E ratio (TTM)131.90—
Forward P/E16.2779.62
EPS (TTM)$1.19$-0.42
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.23B$747.14M
Revenue growth (YoY)-6.33%+26.24%
Net income (latest FY)$732.00K$-44.55M
Gross margin36.84%70.57%
Operating margin1.92%-7.68%
Net margin0.03%-5.96%
52-week high$192.85$212.00
52-week low$112.50$100.70
Distance from 52-week high-18.61%-51.87%
Analyst consensusbuystrong_buy
Avg. price target upside+23.20%+70.44%
Average volume277.57K568.52K
Shares outstanding25.01M32.96M
Employees13,0002,400
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ICUI has outperformed IRTC by 73.0 percentage points over the past year.
  • ICU Medical is more profitable, keeping 0.0 cents of every revenue dollar as net income versus -6.0 cents for iRhythm.
  • iRhythm grew revenue faster in its latest fiscal year (+26.24% vs -6.33%).

About ICU Medical

ICUI stock →

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.

Health Care · Medical/Dental Instruments · 13,000 employees

About iRhythm

IRTC stock →

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

Health Care · Medical/Dental Instruments · 2,400 employees

ICUI vs IRTC FAQ

Which is bigger, ICU Medical or iRhythm?

ICU Medical (ICUI) is larger, with a market capitalization of $3.93B compared with $3.36B for iRhythm (IRTC).

Which stock has performed better over the past year, ICUI or IRTC?

ICUI returned +32.12% over the past 12 months, compared with -40.89% for IRTC (price return, excluding dividends). Past performance does not predict future results.

Are ICU Medical and iRhythm in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons